why choose us

First received: January 20, 2023

Clinical Trial: Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Primary Ciliary Dyskinesia

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study, in Healthy Adult Participants and Open-Label Single Ascending Dose Study in Adults With Primary Ciliary Dyskinesia

Brief Summary: This is the first-in-human study with RCT1100 and is designed to provide initial safety and tolerability data for future clinical studies.

Read more